North America Nuclear Medicine Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)
The North America nuclear medicine market was valued at USD 5,624 million in 2020 and is projected to be worth USD 10,273 million by 2026 registering a CAGR of 10. 4%, over the forecast period 2021-2026.
May 14, 2021 10:49 ET
| Source:
ReportLinker
ReportLinker
Lyon, FRANCE
New York, May 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Nuclear Medicine Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)" - https://www.reportlinker.com/p06030455/?utm_source=GNW
Several general principles have been implemented by government organizations with key goals to reduce disease transmission, preserve healthcare system functioning, protect healthcare workers, and ultimately reduce mortality and morbidity. A new set of regulations for the protection of the staff in the imaging centers and other nuclear facilities were rolled out. In 2020, the United States Food and Drug Administration (US FDA), has developed guidelines to assist nuclear medicine departments to change operating procedures to reduce the risk of COVID-19 infection among patients, staff, and the public. The guidelines also address the possible shortage of critical thinking radiopharmaceuticals due to air traffic restrictions.